Andrew B. Sharabi
- Oncology top 1%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Cancer Research top 5%
- Co-authors
- Charles G. DrakeTheodore L. DeWeeseMichael LimRazelle KurzrockShumei KatoAaron M. GoodmanDonald A. BarkauskasVighnesh Walavalkar
- Topics
- Cancer Immunotherapy and Biomarkers (28 papers)Immunotherapy and Immune Responses (15 papers)Head and Neck Cancer Studies (12 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesNetherlandsThailand
In The Last Decade
Andrew B. Sharabi
76 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 2.5k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 861
- Cancer Research 587
Countries citing papers authored by Andrew B. Sharabi
This map shows the geographic impact of Andrew B. Sharabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew B. Sharabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew B. Sharabi more than expected).
Fields of papers citing papers by Andrew B. Sharabi
This network shows the impact of papers produced by Andrew B. Sharabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew B. Sharabi. The network helps show where Andrew B. Sharabi may publish in the future.
Co-authorship network of co-authors of Andrew B. Sharabi
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew B. Sharabi. A scholar is included among the top collaborators of Andrew B. Sharabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew B. Sharabi. Andrew B. Sharabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 34 | |
| 5 | 4 | |
| 6 | 34 | |
| 7 | 13 | |
| 8 | 53 | |
| 9 | 141 | |
| 10 | 47 | |
| 11 | 1 | |
| 12 | 37 | |
| 13 | 46 | |
| 14 | 67 | |
| 15 | Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Ratebreakdown → | 648 |
| 16 | 28 | |
| 17 | 31 | |
| 18 | Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigenbreakdown → | 510 |
| 19 | 0 | |
| 20 | 5 |
About Andrew B. Sharabi
Andrew B. Sharabi is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 79 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (28 papers), Immunotherapy and Immune Responses (15 papers) and Head and Neck Cancer Studies (12 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.3k citations) and Cancer Research (587 citations). Andrew B. Sharabi has collaborated with scholars based in United States, Netherlands and Thailand. Frequent co-authors include Charles G. Drake, Theodore L. DeWeese, Michael Lim, Razelle Kurzrock, Shumei Kato, Aaron M. Goodman, Donald A. Barkauskas, Vighnesh Walavalkar, Vito Quaranta and Brian J. Francica. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.